A European, multicentre, retrospective, non-interventional study (EU-TREAT) of the effectiveness of insulin degludec after switching basal insulin in a population with type 1 or type 2 diabetes.
Thorsten SiegmundNikolaos TentolourisSøren T KnudsenAnnunziata LapollaRudolf PragerTra-Mi PhanMichael L WoldenBernd Schultesnull nullPublished in: Diabetes, obesity & metabolism (2017)
This study demonstrates that switching patients to IDeg from other basal insulins improves glycaemic control and significantly reduces the risk of hypoglycaemia in routine clinical practice.